Drug-induced sleep endoscopy predictors for oral appliance treatment outcome

A. Vroegop, M. Braem, P. Van de Heyning, O. Vanderveken (Edegem, Antwerp, Belgium)

Source: Annual Congress 2013 –Back to basics: the upper airway and physiology in sleep disordered breathing
Session: Back to basics: the upper airway and physiology in sleep disordered breathing
Session type: Oral Presentation
Number: 4615
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Vroegop, M. Braem, P. Van de Heyning, O. Vanderveken (Edegem, Antwerp, Belgium). Drug-induced sleep endoscopy predictors for oral appliance treatment outcome. Eur Respir J 2013; 42: Suppl. 57, 4615

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of an oral appliance for the treatment of obstructive sleep apnea in a Brazilian population
Source: Annual Congress 2013 –Sleep disordered breathing in special situations I
Year: 2013

Patient selection for oral appliance treatment using of functional imaging and drug-induced sleep endoscopy in patients with obstructive sleep apnea
Source: Annual Congress 2010 - The upper airway and oral appliances
Year: 2010

The efficacy of oral appliance in patients with severe obstructive sleep apnea
Source: International Congress 2014 – Sleep disordered breathing 2
Year: 2014

Endoscopy evaluation to predict oral appliance outcomes in obstructive sleep apnoea
Source: Eur Respir J 2016; 47:1410-1419
Year: 2016



APAP and heated humidification in OSA patients with nasopharyngeal complaints. Adherence and functional outcome of sleep
Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques
Year: 2013


The efficacy of CPAP and oral appliances in moderate obstructive sleep apnoea, used as CBO guideline states
Source: International Congress 2014 – Sleep disordered breathing 1
Year: 2014


The use of rifaximin improves sleep disorders in Hepatic Encephalopathy
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


Clinical validation of a novel FOT-based APAP device for treatment of obstructive sleep apnea
Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I
Year: 2015

Monoblock appliance in children with obstructive sleep apnea is an effective treatment modality
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014


Monoblock appliance for treatment of children with sleep disordered breathing
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015


Efficacy testing for oral appliance therapy in obstructive sleep apnea
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021


Beneficial cardiovascular risk factor modification observed in patients with obstructive sleep apnoea following maxillomandibular advancement surgery
Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters
Year: 2014

Effect of central sleep apnoea on severity and short-term prognosis of acute coronary syndrome
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016


Myofunctional treatment of sleep disordered breathing in children
Source: Annual Congress 2013 –Lung function and sleep studies in children: technical aspects and clinical applications
Year: 2013

Feasibility and patient tolerability of transcutaneous electrical stimulation in obstructive sleep apnoea
Source: International Congress 2016 – Treatment options for obstructive sleep apnoea and obesity hypoventilation
Year: 2016


Are there any gender differences in presenting symptoms and outcomes in people treated for obstructive sleep apnoea syndrome?
Source: International Congress 2014 – Sleep disordered breathing 5
Year: 2014

Short term effects of neck-based treatment and monitoring device for positional obstructive sleep apnea
Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II
Year: 2015


Effects of co-existing asthma and OSA on objectively measured sleep and systemic inflammation
Source: International Congress 2015 – Comorbidities in sleep-disordered breathing and sleep-disordered breathing as a comorbidity
Year: 2015


Effect of combined therapy with oral azythromicin and betametasone, and nasal budesonide in children with sleep disordered breathing associated with adenotonsillar hypertrophy and rhinosinusitis
Source: Annual Congress 2013 –Have we advanced in the treatment of sleep disordered breathing?
Year: 2013


Techniques for predicting outcome of therapeutic interventions in respiratory disorders during sleep
Source: Annual Congress 2007 - PG21 - Diagnostic and therapeutic aspects of respiratory disorders during sleep
Year: 2007